Skip to main content

Table 2 Periodontal clinical parameters (mean (SD)) of the sites sampled for molecular analyses in the two clinical groups, at baseline and 4–6 weeks after therapy

From: Positive correlational shift between crevicular antimicrobial peptide LL-37, pain and periodontal status following non-surgical periodontal therapy. A pilot study

 

Stage I-II

Stage III-IV

Pre-SRP

Post-SRP

Pre-SRP

Post-SRP

Clinical parameters

PD (mm)

4.53 (0.52)

3.40 (0.83)***

6.47 (1.51)

5.27 (1.39)***

CAL (mm)

2.13 (0.64)

1.42 (0.51)*

5.94 (1.06)

3.78 ± (0.94)****

% of sites with

PD > 4 mm

12.40 (12.99)

7.00 (10.09)*

47.93 (23.72)

39.13 (27.58)**

BOP

43.00 (29.77)

19.67 (18.03)***

62.07 (29.14)

37.67 (24.03)****

PI

33.67 (23.75)

16.73 (12.00)**

47.93 (29.78)

27.80 (18.74)**

  1. PD = probing depth; CAL = clinical attachment loss; BOP = bleeding on probing; PI = plaque index. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 pre-SRP vs. post-SRP. Two-way ANOVA followed by Sidak’s multiple comparisons test